Remdesivir Did Not Reduce Hospital Stay, Mortality In COVID Patients: WHO
New Delhi: Gilead Sciences Inc's remdesivir had little or no effect on the length of hospital stay of COVID patients or their chances of survival, a clinical trial by the World…